Japan’s Fujifilm Holdings has assembled a team of more than 100 to deal with rising global interest in its anti-flu drug Avigan as clinical trials in China suggest it appears to be an effective treatment for coronavirus.
The spotlight on Avigan, which has the generic name favipiravir, comes as governments and pharmaceutical companies race to find a treatment for the pandemic, which has infected nearly 200,000 people worldwide.
Shares in the company rose 15 per cent on Wednesday after Chinese authorities reported faster recovery times for those given favipiravir during clinical trials in Wuhan and Shenzhen.
您已阅读21%（613字），剩余79%（2311字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。